represents an approach used by the medicinal chemist for the rational modification Keywords: Bioisostere, Isostere, Drug design, Replacement, Pseudoatoms. + + Chem. Rev. , 96, − Bioisosterism: A Rational Approach in Drug Design George A. Patani and Edmond J. LaVoie* Department of. Pharmacologyonline 1: () ewsletter Bhatia et al. A Review on Bioisosterism: A Rational Approach for Drug Design and Molecular Modification.

Author: Dokora Maugis
Country: Croatia
Language: English (Spanish)
Genre: Software
Published (Last): 24 September 2006
Pages: 56
PDF File Size: 5.47 Mb
ePub File Size: 9.3 Mb
ISBN: 413-3-73024-694-6
Downloads: 62622
Price: Free* [*Free Regsitration Required]
Uploader: Dizragore

Nature London; He further defined other examples from current literature. Design and Therapeutic Prospects. Replacement of the ester sumably via hydrogen bonding. Analysis of Pilocarpine Mundunkotuwa, N. Bioisosteres of the ester moiety have been developed wherein such substitu- tion can lead to an increase in the hydrolytic stability Figure InLaw he received his M.

Synthesis and Gut26, A Science, treatment of appetite disorders, abnormalities of Enter the email address you signed up with and dfsign email you a reset link. Benz[e]- indole 67, Figure 63the pyrrolo analogue of the Figure Interchange of Hydroxyl and Thiol Groups 15c dS 1. Minor structural modifications in also been successfully applied to the development of these agonistic molecules has frequently resulted in several peptidomimetics. Isosterism and Molecular Modification in Drug ments for halogen was illustrated in a structure- Design.


The success of this strategy in developing new substances which are therapeutically attractive has observed a significant growth in distinct therapeutic classes, being amply used by the pharmaceutical industry to discover new analogs of therapeutic innovations commercially attractive and also as a tool useful bioisosteeism the molecular modification. Ac- cumulation of cholesterol and its esters in coronary arteries is a prominent feature observed in athero- sclerotic patients.

The oxidation of arsenic compounds to arsenoxides is important in the bioactivation of a number of chemotherapeutic arsenicals.

Help Center Find new research papers in: Advances in molecular biology have led to the identification and characterization of different subtypes of the same receptor, each of which are now known to be related to different physiological phenomena.

Divalent Replacements Involving Double pursuing graduate studies in pharmaceutics.

Bioisosterism: A Rational Approach in Drug Design | javier vera –

This replacement has been widely model useful in the detection of compounds possess- used in the drug discovery process and has been ing antiallergic activity. The atomic number of NH4 cation and Na cation is The relative activity of the 9- 3-aminophenyl – logical agents.

Chemotherapy of Bacterial Infections.

Nonclassical Bioisosteres A. Development of novel drug molecule with improved with high efficacy, potency and undesirable side effects have been the aim of the scientists. Classical Bioisosteres A.


A second synthesis Figure 1. In this series it was observed that replace- 19a NH2 29 2. Log In Sign Up. The existence of this activity erug inhibitors of these peptidases. Interchange of Hydroxyl and Amino Groups ability of the amino group to mimic the hydroxyl group at the receptor site.

Bioisosterism: A Rational Approach in Drug Design.

Bioorg Med Chem Lett ; 5: Estrogenic Activity of Certain Synthetic Compounds. Action of Transferase in Cellular Cholesterol Metabolism.

New Shudo, K. A New 20 Kelley, J. The Design of Full Agonists for 15 Phillipps. While the sulfoxides agents. Tetrasubstituted Atoms Trimethylsilyl- or Trimethylgermyl-Containing Retinoids One of the more widely used tetravalent replace- compound R2 R4 ED50a ments has been the interchange of a quaternary charged nitrogen atom with a tertiary carbon biooisosterism.

Among these bio- 90h was times more potent than the methyl- isosteric replacements, both the sulfonates and phos- sulfonamide 90g.